Question 1

What is Gvoke HypoPen?

Accepted Answer

Gvoke HypoPen is a stabilized formulation of glucagon, a hormone that occurs naturally in the body. It functions as a hyperglycemic agent used to increase blood glucose levels during severe hypoglycemic events.

The medication works by stimulating the liver to release stored glycogen, which is then converted into glucose and released into the bloodstream. This process helps restore blood sugar to a safer range when levels have dropped dangerously low.

Question 2

What is Gvoke HypoPen used for?

Accepted Answer

Gvoke HypoPen is used to treat severe hypoglycemia .

Question 3

How does Gvoke HypoPen work?

Accepted Answer

Mechanism of Action

Gvoke HypoPen contains glucagon, a hormone that is naturally produced by the pancreas. Its primary role is to increase blood glucose levels when they become dangerously low.

When injected, the medication works through the following process:

Glucose Release: It signals the liver to break down stored sugar, known as glycogen, into glucose.

Bloodstream Entry: This glucose is then released directly into the bloodstream.

Restoring Balance: As blood sugar levels rise, the symptoms of severe hypoglycemia begin to improve.

This process is essential during a diabetic emergency when a person is unable to consume sugar by mouth due to confusion, unconsciousness, or the inability to swallow.

Question 4

What are the active ingredients in Gvoke HypoPen?

Accepted Answer

The active ingredient in Gvoke HypoPen is Glucagon .

Question 5

What are the side effects of Gvoke HypoPen?

Accepted Answer

Common side effects of Gvoke HypoPen may include:

Nausea

Vomiting

Headache

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Gvoke HypoPen?

Accepted Answer

Gvoke HypoPen belongs to the glucagon drug class.

Question 7

What is the dosage of Gvoke HypoPen and how do I take it?

Accepted Answer

How to Use the HypoPen

The Gvoke HypoPen is a single-use autoinjector. It should be administered immediately when severe low blood sugar is recognized. Common injection sites include the lower abdomen, the outer thigh, or the outer upper arm.

To use the device:

Pull the red cap off the device.

Push and hold the yellow end of the device firmly against the skin.

Continue holding for several seconds until the viewing window turns completely yellow, indicating the dose has been delivered.

After Administration

After giving the injection, call for emergency medical assistance right away. If the person is unconscious, turn them on their side to prevent choking if they vomit.

If the person does not respond or wake up within 15 minutes, a second dose may be administered if another device is available and emergency help has not yet arrived.

Follow-up Care

Once the person is conscious and able to swallow safely, they should consume a fast-acting source of sugar, such as fruit juice or glucose gel. This should be followed by a snack containing both protein and carbohydrates, such as crackers with cheese or peanut butter, to help maintain blood sugar levels.

Storage and Handling

Store the device at room temperature in its original sealed foil pouch. Do not refrigerate or freeze the autoinjector. Periodically check the viewing window; the liquid should be clear and colorless or pale yellow. Do not use if the liquid is cloudy or contains particles.

Question 8

Is Gvoke HypoPen safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Glucagon is a hormone that occurs naturally in the human body. Decades of clinical use suggest that using glucagon during pregnancy does not increase the risk of major birth defects, miscarriage, or other adverse health outcomes for the mother or the baby. Research indicates that the medication does not cross the placenta in significant amounts.

Breastfeeding

It is currently unknown if glucagon passes into human breast milk or what effects it may have on a nursing infant. However, because glucagon is a protein, it is expected to be broken down in the infant's digestive system, which makes it unlikely to cause harm. There is no evidence that the medication affects milk production.

Patients are encouraged to discuss the use of this medication with their healthcare provider if they are pregnant, breastfeeding, or planning to become pregnant.

Question 9

What forms and strengths does Gvoke HypoPen come in?

Accepted Answer

Gvoke HypoPen is provided as a pre-filled, single-use autoinjector. It contains a stable liquid formulation of glucagon, which eliminates the need for manual mixing or reconstitution before use.

The device is designed for subcutaneous injection and features an automated delivery system. Once activated, the needle retracts into the device after the dose is delivered.

This medication is available in different sizes intended for use based on the patient's age or weight, though each utilizes the same autoinjector technology.

Question 10

What is the FDA approval status of Gvoke HypoPen?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Gvoke in September 2019. It is indicated for the treatment of severe hypoglycemia (extremely low blood sugar) in adult and pediatric patients aged 2 years and older who have diabetes.

Regulatory Status

Gvoke is classified as a prescription-only medication. It was the first liquid-stable glucagon formulation approved for use in a pre-filled autoinjector. Unlike traditional glucagon emergency kits that require the user to manually mix a powder and liquid before administration, this regulatory approval covered a ready-to-use format designed for rapid delivery during an emergency.

Safety Oversight

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for Gvoke HypoPen. The medication has not been subject to major safety-related recalls or public health communications since its initial approval. It is intended for use only in emergency situations where the patient is unable to consume oral carbohydrates due to severe low blood sugar.

Question 11

What should I know about Gvoke HypoPen and hypoglycemia?

Accepted Answer

Treating Severe Hypoglycemia

Severe hypoglycemia is a medical emergency that occurs when blood sugar levels drop so low that a person requires assistance from others. Symptoms may include extreme confusion, seizures, or loss of consciousness. Gvoke HypoPen is used to quickly raise blood sugar levels by triggering the liver to release stored glucose into the bloodstream.

When to Use Gvoke HypoPen

This medication should be used if a person with diabetes is experiencing very low blood sugar and:

Is unable to swallow or eat safely.

Is unconscious or having a seizure.

Does not respond to oral sugar treatments.

Emergency Steps

Because severe hypoglycemia is life-threatening, certain steps should be taken during and after administration:

Administer the injection: Use the autoinjector in the outer thigh, upper outer arm, or buttock.

Call for help: Contact emergency medical services immediately after giving the dose.

Positioning: Turn the person onto their side to prevent choking, as vomiting is a common side effect of glucagon.

Follow-up: Once the person is conscious and able to swallow, they should consume a fast-acting source of sugar, such as fruit juice or glucose tablets, followed by a long-acting carbohydrate like a snack with protein.

Gvoke HypoPen

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Hypoglycemia Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?